Vor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant.
Location: United States, Massachusetts, Cambridge
Employees: 51-200
Founded date: 2015
Investors 1
| Date | Name | Website |
| - | SymBiosis | symbiosis.... |
Mentions in press and media 2
| Date | Title | Description | Source |
| 05.03.2024 | Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5... | - | globenewsw... |
| 29.09.2022 | Vor Bio opts to keep manufacturing operations in-hous... | While it is not uncommon for a biotech to go down the route of having the product manufacture... | endpts.com... |